Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

410 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Effectiveness of Cladribine in Multiple Sclerosis: Real-World Clinical Experience From 5 Tertiary Hospitals in Portugal.
Santos M, Sequeira J, Abreu P, Guerreiro R, Santos M, Ferreira J, Brum M, Ladeira F, Leitão L, Dias R, Sá MJ, Salgado V, Capela C, de Sá J. Santos M, et al. Among authors: sequeira j. Clin Neuropharmacol. 2023 May-Jun 01;46(3):105-111. doi: 10.1097/WNF.0000000000000552. Epub 2023 Apr 11. Clin Neuropharmacol. 2023. PMID: 37191564
[No title available]
[No authors listed] [No authors listed] PMID: 37036904
REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal.
Batista S, Nunes CC, Cerqueira JJ, Martins Silva A, Correia de Sá J, Ferreira J, Mendonça MT, Pinheiro J, Salgado V, Correia AS, Sequeira J, Costa A, Sousa L. Batista S, et al. Among authors: sequeira j. Neurol Sci. 2021 May;42(5):1995-2003. doi: 10.1007/s10072-020-04726-6. Epub 2020 Sep 30. Neurol Sci. 2021. PMID: 32997282 Free PMC article.
Correction to: REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal.
Batista S, Nunes CC, Cerqueira JJ, Silva AM, de Sá JC, Ferreira J, Mendonça MT, Pinheiro J, Salgado V, Correia AS, Sequeira J, Costa A, Sousa L. Batista S, et al. Among authors: sequeira j. Neurol Sci. 2021 Feb;42(2):767. doi: 10.1007/s10072-020-04879-4. Neurol Sci. 2021. PMID: 33165747 Free PMC article. No abstract available.
HBV and VZV seroprotection loss in MS patients under DMT.
Ladeira F, Oliveira T, Soares M, Araujo C, Sousa A, Brum M, Sequeira J, Capela C. Ladeira F, et al. Among authors: sequeira j. Mult Scler Relat Disord. 2023 Feb;70:104490. doi: 10.1016/j.msard.2022.104490. Epub 2022 Dec 28. Mult Scler Relat Disord. 2023. PMID: 36621160
Gelastic seizures: a retrospective study in five tertiary hospital centres.
Loução de Amorim I, Pereira C, Sequeira J, Rocha H, Peralta AR, Rego R, Bentes C, Bento C, Sales F, Robalo C, Pimentel J. Loução de Amorim I, et al. Among authors: sequeira j. Epileptic Disord. 2020 Apr 1;22(2):165-175. doi: 10.1684/epd.2020.1153. Epileptic Disord. 2020. PMID: 32364505
[Pulmonary embolism--mortality risk].
Sequeira JF, Duarte PC, Madruga IM, Boaventura I, Gomes RM, Miranda MP, Sarmento JL. Sequeira JF, et al. Rev Port Cardiol. 1992 Sep;11(9):749-57. Rev Port Cardiol. 1992. PMID: 1476767 Portuguese.
410 results